Kun Ming KingBio Biotechnology Co. LTD Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2014
NCT02191384
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now